Cargando…
Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report
BACKGROUND: The prognosis of patients with recurrent gastric cancer is poor despite chemotherapy being clinically recommended as the first therapeutic strategy. Recent clinical trials have established the clinical utility of nivolumab in the third-line treatment of such patients. Immune-related adve...
Autores principales: | Arigami, Takaaki, Matsushita, Daisuke, Okubo, Keishi, Tanaka, Takako, Sasaki, Ken, Noda, Masahiro, Kita, Yoshiaki, Mori, Shinichiro, Tsuruda, Yusuke, Kurahara, Hiroshi, Ohtsuka, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572942/ https://www.ncbi.nlm.nih.gov/pubmed/33074364 http://dx.doi.org/10.1186/s40792-020-01050-1 |
Ejemplares similares
-
Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report
por: Matsumoto, Ryu, et al.
Publicado: (2020) -
A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancer
por: Arigami, Takaaki, et al.
Publicado: (2022) -
The Diagnostic and Prognostic Value of a Liquid Biopsy for Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Matsushita, Daisuke, et al.
Publicado: (2020) -
Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature review
por: Sasaki, Ken, et al.
Publicado: (2020) -
Clinical impact of creatine phosphokinase and c-reactive protein as predictors of postgastrectomy complications in patients with gastric cancer
por: Okubo, Keishi, et al.
Publicado: (2021)